Congenital cricopharyngeal achalasia: Management with botulinum toxin before myotomy

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 5, 2005, Pages 451-453

  Sewell, Ryan K ^a,b   Bauman, Nancy M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; OMEPRAZOLE;

ARTICLE; BREATHING; CASE REPORT; CONGENITAL DISORDER; CRICOPHARYNGEAL ACHALASIA; DYSPHAGIA; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS MOTILITY; FOOD REGURGITATION; HUMAN; HYDRAMNIOS; LARYNGOSCOPY; MALE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY COMPLICATION; STRIDOR; SWALLOWING; UPPER ESOPHAGUS SPHINCTER; VOMITING;

BOTULINUM TOXINS; ESOPHAGEAL ACHALASIA; HUMANS; INFANT, NEWBORN; MALE;

EID: 18344368530     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.5.451     Document Type: Article

References (13)

1. Brooks A, Millar AJW, Rode H. The surgical management of cricopharyngeal achalasia in children. Int J Pediatr Otorhinolaryngol. 2000;56:1-7.
2. Shaw GY, Searl JP. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia. 2001; 16:161-167.
3. Ahsan SF, Meleca RJ, Dworkin JP. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolarynol Head Neck Surg. 2000;122:691-695.
4. Townsend CM, ed. Sabiston Textbook of Surgery. 16th ed. Philadelphia, Pa: WB Saunders Co; 2001;716-720.
5. Salib SA, Aubert D, Valioulis I, de Billy B. Cricopharyngeal achalasia - a cause of major dysphagia in a newborn: a case report. Eur J Pediatr Surg. 1999;9:406-408.
6. Utian HL, Thomas RG. Cricopharyngeal incoordination in infancy. Pediatrics. 1969;43:402-406.
7. Mathur NB, Banerjee S, Maria A, Bhatnagar V. Congenital cricopharyngeal achalasia. Indian Pediatr. 2001;38:783-788.
8. Hussain SZ, Di Lorenzo C. Motility disorders: diagnosis and treatment for the pediatric patient. Pediatr Clin North Am. 2002;49:27-51.
9. Skinner MA, Shorter NA. Primary neonatal cricopharyngeal achalasia: a case report and review of the literature. J Pediatr Surg. 1992;27:1509-1511.
10. Bauman NM, Bishop WP, Sandler AD, Smith RJH. Value of pH probe testing in pediatric patients with extraesophageal manifestations of gastroesophageal reflux disease: a retrospective review. Ann Otol Rhinol Laryngol Suppl. 2000;184:18-24.
11. Simpson LL. Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs. Biochimie. 2000; 82:943-953.
12. Ip KS, Cameron DJS, Catto-Smith AG, Hardikar W. Achalasia: botulinum toxin for achalasia in children. J Gastroenterol Hepatol. 2000;15:1100-1104.
13. Hurwitz M, Bahar RJ, Ament ME, et al. Evaluation of the use of botulinum toxin in children with achalasia. J Pediatr Gastroenterol Nutr. 2000; 30:509-513.